Literature DB >> 2672834

Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.

I A Quakyi1, L N Otoo, D Pombo, L Y Sugars, A Menon, A S De Groot, A Johnson, D Alling, L H Miller, M F Good.   

Abstract

Synthetic subunit vaccines to sporozoites, merozoites, and gametes are being developed for malaria. The vaccine strategy assumes that the population to be immunized will respond favorably to these vaccine antigens. Using sera of 35 adults and 50 children from the The Gambia, West Africa, where Plasmodium falciparum is highly endemic, we examined the humoral immune response to candidate malaria vaccine antigens from sporozoites, merozoites, and gametes. We observed widespread restricted immunogenicity to defined parasite antigens in children and adults. HLA typing of adult lymphocytes demonstrated a marked diversity in HLA haplotypes in this population. Our results and those from our studies in mice suggest that genetic factors may partly explain the immunological non-responsiveness. This may necessitate re-evaluation of the malaria vaccine strategy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672834

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Development of natural immunity in Plasmodium falciparum malaria: study of antibody response by Western immunoblotting.

Authors:  J Thelu; I Sheick-Zakiuddin; C Boudin; F Peyron; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.

Authors:  B Wizel; N Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

4.  Naturally acquired IgG antibodies against the C-terminal part of Plasmodium falciparum sporozoite threonine-asparagine-rich protein in a low endemic area.

Authors:  Chittakun Suwancharoen; Chaturong Putaporntip; Thanaporn Rungruang; Somchai Jongwutiwes
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

5.  Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area.

Authors:  A Dieye; H G Heidrich; C Rogier; J F Trape; P Launois; A A Holder; J L Sarthou
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.

Authors:  Mayumi Tachibana; Yimin Wu; Hideyuki Iriko; Olga Muratova; Nicholas J MacDonald; Jetsumon Sattabongkot; Satoru Takeo; Hitoshi Otsuki; Motomi Torii; Takafumi Tsuboi
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

7.  Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans.

Authors:  B Galey; P Druilhe; I Ploton; C Desgranges; A Asavanich; T Harinasuta; C Marchand; K Brahimi; Y Charoenvit; C Paul
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

8.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.

Authors:  E Scarselli; R Tolle; O Koita; M Diallo; H M Müller; K Früh; O Doumbo; A Crisanti; H Bujard
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.

Authors:  Dari F Da; Saurabh Dixit; Jetsumon Sattabonkot; Jianbing Mu; Luc Abate; Bhanumati Ramineni; Jean Bosco Ouedraogo; Nicholas J MacDonald; Michael P Fay; Xin-zhuan Su; Anna Cohuet; Yimin Wu
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.